EUVIMEDEUVIMED entdecken
Querschnittstudie

Diagnostic Performance and Comparative Analysis of Conventional Drug Susceptibility Testing, Line Probe Assay, and GeneXpert in Extrapulmonary Tuberculosis Cases: A Cross-sectional Observational Study

Pawan Patidar, Yogendra Kumar Tiwari, Nikita Patidar

International Journal of Current Pharmaceutical Review and Research · 30.04.2026 · 18 (04)

DOI: 10.25258/ijcpr.18.4.186 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.04.2026. Verfasst von Pawan Patidar und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Extrapulmonary tuberculosis (EPTB) remains a significant diagnostic challenge due to its paucibacillary nature, atypical clinical presentation, and difficulty in obtaining adequate samples. Conventional diagnostic methods such as culture and drug susceptibility testing (DST), although considered gold standards, are time-consuming and delay treatment initiation. Rapid molecular diagnostic tools like GeneXpert MTB/RIF and Line Probe Assay (LPA) have emerged as effective alternatives for early detection of Mycobacterium tuberculosis and associated drug resistance.

Aim

To evaluate and compare the diagnostic performance of conventional drug susceptibility testing, Line Probe Assay, and GeneXpert MTB/RIF in detecting Mycobacterium tuberculosis and drug resistance in extrapulmonary tuberculosis cases. Material and Methods: This cross-sectional observational study was conducted over a period of 9 months at the ICMR-NITVAR (National Institute for Translational Virology and AIDS Research), Pune, India. A total of 100 patients clinically suspected of extrapulmonary tuberculosis were included. Various extrapulmonary samples, including pleural fluid, cerebrospinal fluid, lymph node aspirates, ascitic fluid, and pus, were collected and processed. All samples were subjected to Ziehl–Neelsen staining, culture on standard media, and conventional DST. Molecular testing was performed using GeneXpert MTB/RIF assay and Line Probe Assay. Diagnostic accuracy parameters including sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated using culture/DST as the reference standard. Statistical analysis was performed using appropriate tests, with a p-value

Zitieren

APA

Patidar, P., Tiwari, Y. K., & Patidar, N. (2026). Diagnostic Performance and Comparative Analysis of Conventional Drug Susceptibility Testing, Line Probe Assay, and GeneXpert in Extrapulmonary Tuberculosis Cases: A Cross-sectional Observational Study. International Journal of Current Pharmaceutical Review and Research, 18(04). https://doi.org/10.25258/ijcpr.18.4.186

Vancouver

Patidar P, Tiwari YK, Patidar N. Diagnostic Performance and Comparative Analysis of Conventional Drug Susceptibility Testing, Line Probe Assay, and GeneXpert in Extrapulmonary Tuberculosis Cases: A Cross-sectional Observational Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(04). doi:10.25258/ijcpr.18.4.186

BibTeX
@article{Patidar2026,
  author = {Patidar, Pawan and Tiwari, Yogendra Kumar and Patidar, Nikita},
  title = {Diagnostic Performance and Comparative Analysis of Conventional Drug Susceptibility Testing, Line Probe Assay, and GeneXpert in Extrapulmonary Tuberculosis Cases: A Cross-sectional Observational Study},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {04},
  doi = {10.25258/ijcpr.18.4.186}
}
Kostenlos starten →